{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:41:27Z","timestamp":1791200487534,"version":"4.2.0"},"reference-count":48,"publisher":"ARAN Ediciones","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.hipert.2024.03.004","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T22:52:56Z","timestamp":1717887176000},"page":"186-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Diuretics use in the management of hypertension"],"prefix":"10.20960","volume":"41","author":[{"given":"F.J.","family":"Morales-Olivas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8588","reference":[{"key":"10.1016\/j.hipert.2024.03.004_bib0245","series-title":"Observatorio de uso de medicamentos. Informe sobre utilizaci\u00f3n de f\u00e1rmacos antihipertensivos","year":"2021"},{"key":"10.1016\/j.hipert.2024.03.004_bib0250","first-page":"445","article-title":"Drug affecting renal excretory function","author":"Jackson","year":"2018"},{"key":"10.1016\/j.hipert.2024.03.004_bib0255","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.semnephrol.2011.09.003","article-title":"Update in diuretic therapy: clinical pharmacology","volume":"31","author":"Brater","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.hipert.2024.03.004_bib0260","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20220977","article-title":"Kidney ion handling genes and their interaction in blood pressure control","volume":"42","author":"An","year":"2022","journal-title":"Biosci Rep"},{"key":"10.1016\/j.hipert.2024.03.004_bib0265","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ng.118","article-title":"Rare independent mutations in renal salt handling genes contribute to blood pressure variation","volume":"40","author":"Ji","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.hipert.2024.03.004_bib0270","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/ajh\/hpac048","article-title":"Thiazide and the thiazide-like diuretics: review of hydrochlorothiazide, chlorthalidone, and indapamide","volume":"35","author":"Ernst","year":"2022","journal-title":"Am J Hypertens"},{"issue":"suppl. 2","key":"10.1016\/j.hipert.2024.03.004_bib0275","first-page":"12","article-title":"Diferencias y similitudes entre diur\u00e9ticos","volume":"30","author":"Morales-Olivas","year":"2013","journal-title":"Hipertens Riesgo Vasc"},{"key":"10.1016\/j.hipert.2024.03.004_bib0280","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","volume":"304","author":"MRC Working Party","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.hipert.2024.03.004_bib0285","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.semnephrol.2011.09.009","article-title":"Metabolic complications associated with use of diuretics","volume":"31","author":"Palmer","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.hipert.2024.03.004_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M23-1989","article-title":"Cumulative incidence of thiazide-induced hyponatremia: a population-based cohort study","volume":"177","author":"Andersson","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hipert.2024.03.004_bib0295","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.HYP.0000125726.92964.ab","article-title":"Adverse prognostic significance of new diabetes in treated hypertensive subjects","volume":"43","author":"Verdecchia","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.hipert.2024.03.004_bib0300","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/CIRCOUTCOMES.111.962522","article-title":"Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study","volume":"5","author":"Barzilay","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.hipert.2024.03.004_bib0305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.HYP.29.1.8","article-title":"Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)","volume":"29","author":"Grimm","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.hipert.2024.03.004_bib0310","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.hipert.2024.03.004_bib0315","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","article-title":"Blood pressure, stroke and coronary heart disease \u2013 part 2, short term reduction in blood pressure: overview of randomised drug trials in epidemiological context","volume":"335","author":"Collins","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.hipert.2024.03.004_bib0320","first-page":"1","article-title":"New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit","volume":"10","author":"Gueyffier","year":"1996","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.hipert.2024.03.004_bib0325","first-page":"CD008276","article-title":"Pharmacotherapy for hypertension in adults aged 18 to 59 years","volume":"8","author":"Musini","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hipert.2024.03.004_bib0330","first-page":"CD000028","article-title":"Pharmacotherapy for hypertension in adults 60 years or older","volume":"6","author":"Musini","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hipert.2024.03.004_bib0335","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data metaanalysis","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.hipert.2024.03.004_bib0340","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","article-title":"Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.hipert.2024.03.004_bib0345","first-page":"25","article-title":"Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?","volume":"161","author":"Wright","year":"1999","journal-title":"CMAJ"},{"key":"10.1016\/j.hipert.2024.03.004_bib0350","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials","volume":"362","author":"Turnbull","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hipert.2024.03.004_bib0355","first-page":"CD008161","article-title":"First-line diuretics versus other classes of antihypertensive drugs for hypertension","volume":"7","author":"Reinhart","year":"2023","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.hipert.2024.03.004_bib0360","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/HJH.0000000000002088","article-title":"Redefining diuretics use in hypertension: why select a thiazide-like diuretic?","volume":"37","author":"Burnier","year":"2019","journal-title":"J Hypertens"},{"key":"10.1016\/j.hipert.2024.03.004_bib0365","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2010.07.053","article-title":"Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials","volume":"57","author":"Messerli","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hipert.2024.03.004_bib0370","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ajh.2010.1","article-title":"Meta-analysis of dose\u2013response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium","volume":"23","author":"Ernst","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.hipert.2024.03.004_bib0375","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/HYPERTENSIONAHA.111.190637","article-title":"Meta-analysis of dose\u2013response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate","volume":"59","author":"Peterzan","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.hipert.2024.03.004_bib0380","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/HYPERTENSIONAHA.114.05122","article-title":"Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis","volume":"65","author":"Olde Engberink","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.hipert.2024.03.004_bib0385","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/HJH.0000000000002771","article-title":"Chlorthalidone versus hydrochlorothiazide: major cardiovascular events, blood pressure, left ventricular mass, and adverse effects","volume":"39","author":"Roush","year":"2021","journal-title":"J Hypertens"},{"key":"10.1016\/j.hipert.2024.03.004_bib0390","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1056\/NEJMoa2212270","article-title":"Chlorthalidone vs. hydrochlorothiazide for hypertension-cardiovascular events","volume":"387","author":"Ishani","year":"2022","journal-title":"NEJM"},{"key":"10.1016\/j.hipert.2024.03.004_bib0395","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMe2215744","article-title":"Thiazide-like versus thiazide diuretics \u2013 finally, an answer?","volume":"387","author":"Ingelfinger","year":"2022","journal-title":"NEJM"},{"key":"10.1016\/j.hipert.2024.03.004_bib0400","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMc2301922","article-title":"Chlorthalidone vs. hydrochlorothiazide for hypertension-cardiovascular events","volume":"388","author":"Messerli","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hipert.2024.03.004_bib0405","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/j.jacc.2019.03.507","article-title":"ACC\/AHA versus ESC\/ESH on hypertension guidelines","volume":"73","author":"Bakris","year":"2019","journal-title":"JACC"},{"key":"10.1016\/j.hipert.2024.03.004_bib0410","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/HJH.0000000000002065","article-title":"Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals","volume":"37","author":"Gij\u00f3n-Conde","year":"2019","journal-title":"J Hypertens"},{"key":"10.1016\/j.hipert.2024.03.004_bib0415","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/s41440-021-00666-6","article-title":"Why we need a single independent international hypertension clinical practice guideline","volume":"44","author":"Ben-Eltriki","year":"2021","journal-title":"Hypertens Res"},{"key":"10.1016\/j.hipert.2024.03.004_bib0420","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/HJH.0000000000002940","article-title":"Why we do not need a single independent international hypertension clinical practice guideline","volume":"39","author":"Kreutz","year":"2021","journal-title":"J Hypertens"},{"key":"10.1016\/j.hipert.2024.03.004_bib0425","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.hipert.2022.09.002","article-title":"Gu\u00eda pr\u00e1ctica sobre el diagn\u00f3stico y tratamiento de la hipertensi\u00f3n arterial en Espa\u00f1a, 2022. Sociedad Espa\u00f1ola de Hipertensi\u00f3n - Liga Espa\u00f1ola para la Lucha contra la Hipertensi\u00f3n Arterial (SEH-LELHA)","volume":"39","author":"Gorostidi","year":"2022","journal-title":"Hipertens Riesgo Vasc"},{"key":"10.1016\/j.hipert.2024.03.004_bib0430","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.hipert.2024.03.004_bib0435","doi-asserted-by":"crossref","first-page":"e1921618","DOI":"10.1001\/jamanetworkopen.2019.21618","article-title":"Comparison of cardiovascular events among users of different classes of antihypertension medications: a systematic review and network meta-analysis","volume":"3","author":"Wei","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hipert.2024.03.004_bib0440","doi-asserted-by":"crossref","first-page":"101927","DOI":"10.1016\/j.cpcardiol.2023.101927","article-title":"Clinical outcomes with furosemide versus torsemide in patients with heart failure: an updated systematic review and meta-analysis","volume":"48","author":"Siddiqi","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.hipert.2024.03.004_bib0445","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.hipert.2024.03.004_bib0450","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2022-321730","article-title":"Diagnosis and management of resistant hypertension","author":"Camafort","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.hipert.2024.03.004_bib0455","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","article-title":"Morbidity and mortality in patients randomized to double-blind treatment with long-acting calcium-channel blocker on diuretic in the International Nifedipine GTS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT)","volume":"356","author":"Brown","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.hipert.2024.03.004_bib0460","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/HJH.0000000000003436","article-title":"Thiazide diuretics alone or combined with potassium-sparing diuretics to treat hypertension: a systematic review and network meta-analysis of randomized controlled trials","volume":"41","author":"Martins","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.hipert.2024.03.004_bib0465","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa2213169","article-title":"Phase 2 trial of Baxdrostat for treatment-resistant hypertension","volume":"388","author":"Freeman","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hipert.2024.03.004_bib0470","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jama.2023.16029","article-title":"Aldosterone synthase inhibition with lorundrostat for uncontrolled hypertension: the target-HTN randomized clinical trial","volume":"330","author":"Laffin","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.hipert.2024.03.004_bib0475","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1093\/eurheartj\/ehn427","article-title":"Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials","volume":"29","author":"Turnbull","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hipert.2024.03.004_bib0480","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1093\/eurheartj\/ehac470","article-title":"Sex differences in arterial hypertension","volume":"43","author":"Gerdts","year":"2022","journal-title":"Eur Heart J"}],"container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183724000540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183724000540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:15:35Z","timestamp":1784596535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1889183724000540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1889183724000540"],"URL":"https:\/\/doi.org\/10.1016\/j.hipert.2024.03.004","relation":{},"ISSN":["1889-1837"],"issn-type":[{"value":"1889-1837","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diuretics use in the management of hypertension","name":"articletitle","label":"Article Title"},{"value":"Hipertensi\u00f3n y Riesgo Vascular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hipert.2024.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEH-LELHA.","name":"copyright","label":"Copyright"}]}}